| 1 |
matrix metalloproteinase-2
(4577 times)
|
Neoplasms
(746 times)
|
MMP-9 (394 times)
VEGF (301 times)
TIMP-2 (239 times)
|
1990 Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties.
|
| 2 |
matrix metalloproteinase protein-2
(6 times)
|
Chemistry
(1 time)
|
AP (1 time)
CYR61 (1 time)
F-GLP-1 (1 time)
|
2003 [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
|
| 3 |
metalloproteinase genes-metalloproteinase-2
(3 times)
|
Pharmacology
(1 time)
|
ACE (1 time)
BTB (1 time)
CA19-9 (1 time)
|
2010 Association of polymorphisms of zinc metalloproteinases with clinical response to stem cell therapy.
|
| 4 |
mitochondrial membrane potential-2
(2 times)
|
Pharmacognosy
(1 time)
|
COX-2 (1 time)
IL-6 (1 time)
NF-kappaB (1 time)
|
2016 Quercetin Suppresses the Migration and Invasion in Human Colon Cancer Caco-2 Cells Through Regulating Toll-like Receptor 4/Nuclear Factor-kappa B Pathway.
|
| 5 |
MMP-2KO
(2 times)
|
Medicine
(1 time)
|
MMP-9 (2 times)
WT (2 times)
AAA (1 time)
|
2002 Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms.
|
| 6 |
MPO, metalloproteinase 2
(2 times)
|
Neoplasms
(1 time)
|
AUC (1 time)
CC (1 time)
M-CSF (1 time)
|
2019 Diagnostic Power of Cytokine M-CSF, Metalloproteinase 2 (MMP-2) and Tissue Inhibitor-2 (TIMP-2) in Cervical Cancer Patients Based on ROC Analysis.
|
| 7 |
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-matrix metalloproteinase-2
(1 time)
|
Neoplasms
(1 time)
|
CLs (1 time)
PEG (1 time)
|
2023 Doxorubicin-loaded liposomes surface engineered with the matrix metalloproteinase-2 cleavable polyethylene glycol conjugate for cancer therapy.
|
| 8 |
hydroxamate-matrix metalloproteinase-2
(1 time)
|
Molecular Biology
(1 time)
|
FEP (1 time)
MD (1 time)
RESP (1 time)
|
2004 Binding affinity of hydroxamate inhibitors of matrix metalloproteinase-2.
|
| 9 |
major metalloproteinases, gelatinase A, 72 kDa type IV collagenase
(1 time)
|
Molecular Biology
(1 time)
|
MMPs (1 time)
|
2006 Prominent expression of metalloproteinases in early stages of ovarian tumorigenesis.
|
| 10 |
matrix metalloproteinase inhibitor: inhibition of 72-kD type IV collagenase
(1 time)
|
Nephrology
(1 time)
|
MC (1 time)
MMP (1 time)
|
1997 Rat mesangial cells and matrix metalloproteinase inhibitor: inhibition of 72-kD type IV collagenase (MMP-2) and of cell proliferation.
|
| 11 |
matrix metalloproteinase-2; and -9
(1 time)
|
Biology
(1 time)
|
---
|
2016 Casticin Inhibits A375.S2 Human Melanoma Cell Migration/Invasion through Downregulating NF-kappaB and Matrix Metalloproteinase-2 and -1.
|
| 12 |
MEK1/2-ERK1/2 pathway, metalloproteinase-II
(1 time)
|
Cardiology
(1 time)
|
LVSd (1 time)
|
2015 Cardioprotection by curcumin post-treatment in rats with established chronic kidney disease.
|
| 13 |
metal matrix proteinase 2
(1 time)
|
Neoplasms
(1 time)
|
SASH1 (1 time)
|
2020 SASH1 Suppresses the Proliferation and Invasion of Human Skin Squamous Cell Carcinoma Cells via Inhibiting Akt Cascade.
|
| 14 |
metalloproteinase-2 in complex with the inhibitor
(1 time)
|
Biochemistry
(1 time)
|
TIMP-2 (1 time)
|
2007 Serum tissue inhibitor of metalloproteinase-2 (TIMP-2) and matrix metalloproteinase-2 in complex with the inhibitor (MMP-2:TIMP-2) as prognostic markers in bladder cancer.
|
| 15 |
metalloproteinases, the M(r) 72,000 type IV collagenase
(1 time)
|
Neoplasms
(1 time)
|
MMPs (1 time)
|
1992 Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential.
|
| 16 |
metastasis-related metalloproteinase-2
(1 time)
|
Neoplasms
(1 time)
|
HUVEC (1 time)
PTTG (1 time)
RT/PCR (1 time)
|
2006 Regulation of angiogenesis and invasion by human Pituitary tumor transforming gene (PTTG) through increased expression and secretion of matrix metalloproteinase-2 (MMP-2).
|
| 17 |
MMP-12, were also found extracellularly, associated with elastin-containing structures
(1 time)
|
Hematology
(1 time)
|
MMPs (1 time)
SMC (1 time)
WT (1 time)
|
1999 Temporal and topographic matrix metalloproteinase expression after vascular injury in mice.
|
| 18 |
MMP-2 Tg
(1 time)
|
Biochemistry
(1 time)
|
IPC (1 time)
MMPs (1 time)
|
2007 Transgenic MMP-2 expression induces latent cardiac mitochondrial dysfunction.
|
| 19 |
MMP-2-siRNA
(1 time)
|
Medicine
(1 time)
|
ADM (1 time)
|
2012 Involvement of MMP-2 in adriamycin resistance dependent on ERK1/2 signal pathway in human osteosarcoma MG-63 cells.
|
| 20 |
MMP-2/9 were attenuated in the RIPC group
(1 time)
|
Medicine
(1 time)
|
CPB (1 time)
cTnT (1 time)
|
2014 Activities of cardiac tissue matrix metalloproteinases 2 and 9 are reduced by remote ischemic preconditioning in cardiosurgical patients with cardiopulmonary bypass.
|
| 21 |
MMP-2/VEGFR-2 inhibitors, particularly 8d
(1 time)
|
Biochemistry
(1 time)
|
---
|
2022 Targeting the interplay between MMP-2, CA II and VEGFR-2 via new sulfonamide-tethered isomeric triazole hybrids; Microwave-assisted synthesis, computational studies and evaluation.
|
| 22 |
MMP-9, and LMC19 expressed 72-kDa gelatinase
(1 time)
|
Neoplasms
(1 time)
|
MMP-9 (1 time)
|
1993 Effect of epidermal growth factor and transforming growth factor beta 1 on growth and invasive potentials of newly established rat bladder carcinoma cell lines.
|
| 23 |
MMPs; 72-kDa type IV collagenase
(1 time)
|
Critical Care
(1 time)
|
ARDS (1 time)
BALF (1 time)
|
1997 Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome.
|
| 24 |
modulates metalloprotease 2
(1 time)
|
Biochemistry
(1 time)
|
VEGF (1 time)
|
2012 Blocking alphavbeta3 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells.
|
| 25 |
Moreover, peptide 30 inactivated metalloproteinase-2
(1 time)
|
Therapeutics
(1 time)
|
---
|
2011 RGD-modified endostatin peptide 30 derived from endostatin suppresses invasion and migration of HepG2 cells through the alphavbeta3 pathway.
|
A Search Service for Abbreviation / Long Form